A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
about
Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming proteinDown-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma linesIdentification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagenAn Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinasesComputer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytesInteraction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expressionEpstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptorDegradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human seraDifferences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cellsLatent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaBThe Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cellsNucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation siteEpstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders.A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.The analysis of EBV proteins which are antigenic in vivo.Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells.Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation.Epstein-Barr virus and human diseases: recent advances in diagnosisMarked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association.Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cellsAn Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinaseTwo related Epstein-Barr virus membrane proteins are encoded by separate genesDistinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
P2860
Q24599252-33879B53-3C46-4028-AD9B-BD03DE36FAC4Q24605501-3D561539-27A9-4842-AFF4-18B3D358123AQ24633907-30994F5A-A18D-438A-BA8D-40632048EA1BQ24644262-A0FC7990-6FC8-4B3F-B9F0-90E4DF3BFC2BQ30356755-F4C79E7B-D6AD-402A-8FF4-0AACCC60FBCDQ33576126-325C313D-2903-4244-9137-9A114D891A60Q33786551-4EAA352C-67EA-48E0-94FA-D5CF7B4632A7Q33797179-5512FA61-1B5E-41B8-894A-7058CCB13D0FQ33880494-4E76B8D4-3992-4DA7-B3DB-46663A129673Q33880983-FF564333-9F60-47CE-977A-8E3CC30A82EDQ33888498-38DF2F23-CEEB-45FB-98DE-D76360FA6C4BQ33901677-A7D973B0-6B99-493A-991D-FF457EF301C2Q33905718-B605AB88-6E7F-47D6-BC0F-3428B9BD04F5Q33929593-732075C8-CFB1-4F74-A985-4B062147E984Q34250209-AAE5F9BD-6BEF-4825-B5B8-465D4F174C24Q34334755-9C98CAE4-384D-4FDB-BF4C-2ADB3AEDBD77Q35122447-7032280D-B223-405A-817F-84CFEDA3A582Q35139273-26EA57C4-FD35-400F-8827-40641E10130CQ35537283-E7BA5A06-F215-453D-B8D9-9EB156F02EA5Q35593639-FFFD48CE-3B3B-4054-93C9-991FA9E063A8Q35616566-0C75EA80-EBE6-4F63-902B-F62B93C8B367Q35764233-C76D0F56-03AD-49A3-959E-83802586B827Q35831688-2BA15730-5B20-4070-B76D-8A8E7A5D49B9Q35839956-992FA154-1B80-4BBE-861A-1A6EFE5278FBQ35875444-F4FC816D-0A3C-4B80-BA29-F5EEA1B6AE24Q35999054-4F8EA33B-8C49-40B0-B788-39DBDD0A140FQ36028864-45C597C5-0C37-4D3E-8D33-FFF4D84B0E5DQ36327458-19A604E7-3B37-4498-9D1A-F36F82E71C87Q36564433-98B9FAD4-BD81-40E2-8019-A916B04AD986Q36622140-85EBC21F-AC84-4A3F-A8AF-DEDB01FE9C30Q36633160-2A4E2AF1-BC39-426F-A380-7062F7835FA1Q36654123-2E547C85-B301-4451-8839-A8534FF23150Q36682729-A2D69243-F354-46D0-B4BA-B67435089097Q36695348-47E03D6A-EBC6-4685-8401-6F74A90176A4Q36699262-2B3D7075-060F-4B0A-B515-0D4A1AF797D4Q36701288-783A6343-9069-4871-B1A7-9E85451790FCQ36780955-941C2482-1787-401F-8385-AAF65DAC95BCQ36781303-3E2ED878-DE0A-4FBA-89B8-51A38C760A1BQ36792029-008EAAD4-3A7C-4A6F-98B0-A61EAD75F8A2Q36793368-198B05EE-23D1-44FE-958A-307668486A3A
P2860
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
@en
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
@nl
type
label
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
@en
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
@nl
prefLabel
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
@en
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
@nl
P2093
P2860
P356
P1476
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
@en
P2093
P2860
P304
P356
10.1073/PNAS.81.22.7207
P407
P577
1984-11-01T00:00:00Z